Aegis Expands its International and US Intravail® Patent Portfolio on Multiple Fronts
02 août 2018 06h00 HE
|
Aegis Therapeutics LLC
SAN DIEGO, Aug. 02, 2018 (GLOBE NEWSWIRE) -- Aegis Therapeutics LLC announced today that it has been awarded European Patent No. EP2381773(B1) and Canadian Patent No. 2,748,268, providing fast...